Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients

NCT00859014 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

BIOLOGICAL: Autologous Bone Marrow Mononuclear Cells

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

[object Object]
[object Object]